Plateletcrit. A platelet marker associated with saphenous vein graft disease

Herz

Volumn 39, Issue 1, 2014, Pages 142-148

  Akpinar, I ^a   Sayin, M R ^a   Gursoy, Y C ^a   Karabag, T ^a   Kucuk, E ^a   Buyukuysal, M C ^a   Aydin, M ^a   Haznedaroglu, I C ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Graft disease; Platelet; Plateletcrit; Predictive value; Saphenous vein

Indexed keywords

HEMOGLOBIN; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ERYTHROCYTE PARAMETERS; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PLATELET DISTRIBUTION WIDTH; PLATELETCRIT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RED BLOOD CELL DISTRIBUTION WIDTH; SAPHENOUS VEIN GRAFT; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; URIC ACID BLOOD LEVEL; VEIN GRAFT DISEASE; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; REPRODUCIBILITY; SAPHENOUS VEIN; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PLATELET COUNT; REPRODUCIBILITY OF RESULTS; SAPHENOUS VEIN; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84898597827     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-013-3798-y     Document Type: Article

References (34)

1. Izzat MB, West RR, Bryan AJ et al (1994) Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 71:382-385 (Pubitemid 24163695)
2. Tavil Y, Sen N, Yazici HU et al (2010) Relationship between elevated platelet volume and saphenous vein graft disease. Clin Invest Med 33(3):161-167
3. Valkila EH, Salenius JP, Koivula TA (1994) Platelet indices in patients with occlusive carotid artery disease. Angiology 45(5):361-365 (Pubitemid 24142664)
4. Kostrubiec M, Labyk A, Pedowska-Wloszek J et al (2010) Mean platelet volume predicts early death in acute pulmonary embolism. Heart 96(6):460- 465
5. Cil H, Yavuz C, Islamoglu Y et al (2012) Platelet count and mean platelet volume in patients with in-hospital deep venous thrombosis. Clin Appl Thromb Hemost 18(6):650-653
6. Liu R, Gao F, Huo J et al (2012) Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 23(1):11-16
7. Becchi C, Al Malyan M, Fabbri LP et al (2006) Mean platelet volume trend in sepsis: is it a useful parameter? Minerva Anestesiol 72(9):749-756 (Pubitemid 44445754)
8. Yazici HU, Poyraz F, Sen N et al (2011) Relationship between mean platelet volume and left ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction. Clin Invest Med 34(6):330
9. Parang P, Arora R (2009) Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25(2):57-62
10. Ma XY, Liu JP, Song ZY (2012) Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies. Atherosclerosis 223(2):491-496
11. Sulai NH, Tefferi A (2012) Why does my patient have thrombocytosis? Hematol Oncol Clin North Am 26(2):285-301
12. Gauer RL, Braun MM (2012) Thrombocytopenia. Am Fam Physician 85(6):612-622
13. Henning BF, Zidek W, Linder B, Tepel M (2002) Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res 25(2):103-108 (Pubitemid 34665211)
14. Nena E, Papanas N, Steiropoulos P et al (2012) Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 23(6):447-454
15. Erikci AA, Karagoz B, Ozturk A et al (2009) The effect of subclinical hypothyroidism on platelet parameters. Hematology 14(2):115-117
16. Erem C, Ersoz HO, Karti SS et al (2002) Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 25(4):345-350 (Pubitemid 34436130)
17. Bryan AJ, Angelini GD (1994) The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 9: 641- 649
18. Jeremy JY, Mehta D, Bryan AJ et al (1997) Platelets and saphenous vein graft failure following coronary artery bypass surgery. Platelets 8(5):295-309 (Pubitemid 27485402)
19. Motwani JG, Topol EJ (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97:916-931 (Pubitemid 28113931)
20. Goldman S, Zadina K, Moritz T et al (2004) Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery by-pass surgery: results from a department of veterans affairs cooperative study. J Am Coll Cardiol 44:2149-2156 (Pubitemid 39576034)
21. Campeau L, Enjalbert M, Lesperance J et al (1984) The relation ofrisk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary by-pass surgery. N Engl J Med 311:1329-1332 (Pubitemid 15129601)
22. Milazzo D, Biasucci LM, Luciani N et al (1999) Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol 84:459-461 (Pubitemid 29398669)
23. Yilmaz MB, Balbay Y, Caldir V et al (2005) Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 115(1-2):25-29 (Pubitemid 39572751)
24. Gagliardi AC, Miname MH, Santos RD (2009) Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202(1):11-17
25. Ruggiero C, Cherubini A, Ble A et al (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174-1181
26. Ruggiero C, Cherubini A, Miller E et al (2007) Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 100:115-121 (Pubitemid 46961911)
27. Tavil Y, Sen N, Hizal F et al (2008) Relationship between elevated levels of serum uric acid and saphenous vein graft disease. Turk Kardiyol Dern Ars 36(1):14-18
28. Demirkan B, Güray Y, Güray Ü et al (2010) The relationship between saphenous coronary by-pass graft occlusion and serum gamma-glutamyltransferase activity. Turk Kardiyol Dern Ars 38(5):321-326
29. Kalay N, Aytekin M, Kaya MG et al (2011) The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels. Turk Kardiyol Dern Ars 39(6):463-468
30. Lippi G, Targher G, Montagnana M et al (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133:628-632
31. Ferrucci L, Guralnik JM, Woodman RC et al (2005) Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118:1288
32. Shukla N, Jeremy JY (2012) Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Curr Opin Pharmacol 12(2):114- 120
33. Chu SG, Becker RC, Berger PB et al (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8(1):148-156
34. Kuku I, Kaya E, Yologlu S et al (2009) Platelet count in adults with iron deficiency anemia. Platelets 20:401-405